AorTech hits more trouble, continues strategy review
This article was originally published in Clinica
Executive Summary
Little has gone right this year for AorTech International, but this week the words "company break up" were mentioned in the press for the first time in the wake of a warning from the Bellshill, Scotland company that it would record lower sales and an increased loss in the current half year. Sales would be some 45% lower, at £1.1m ($1.7m) in the six months to September 30 2002, and the loss would rise by 40% to some £7m. The ongoing strategy review will continue over the coming weeks, focusing on manufacturing, said a spokesman.